Biomerica (BMRA) Cash from Investing Activities Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2025 | 33.31% |
| May 31, 2024 | 14.31% |
| Feb 29, 2024 | 14.07% |
| Nov 30, 2023 | 13.24% |
| Aug 31, 2023 | -0.78% |
| May 31, 2023 | 24.23% |
| Feb 28, 2023 | 22.44% |
| Nov 30, 2022 | 6.14% |
| Aug 31, 2022 | -11.23% |
| May 31, 2022 | -148.78% |
| Feb 28, 2022 | 23.11% |
| May 31, 2021 | -24.28% |
| Feb 28, 2021 | -19.24% |
| Nov 30, 2020 | -5.22% |
| Aug 31, 2020 | -74.82% |
| May 31, 2020 | -104.28% |
| Feb 29, 2020 | -687.70% |
| Nov 30, 2019 | 18.06% |
| Aug 31, 2019 | -51.72% |
| May 31, 2019 | 20.66% |
| Feb 28, 2019 | -0.38% |
| Nov 30, 2018 | 20.13% |
| Aug 31, 2018 | -47.33% |
| May 31, 2018 | -48.69% |
| Feb 28, 2018 | -25.04% |
| Nov 30, 2017 | 28.57% |
| Aug 31, 2017 | 21.07% |
| May 31, 2017 | -14.91% |
| Feb 28, 2017 | 8.80% |
| May 31, 2016 | 37.24% |
| Feb 29, 2016 | 1.35% |
| Nov 30, 2015 | 26.03% |
| Aug 31, 2015 | 29.04% |